Sincalide CAS:25126-32-3

Sincalide is a synthetic C-terminal octapeptide identical to the sequences of the endogenous cholecystokinin hormone. Mimic action of cholecystokinin, sincalide induces gallbladder smooth muscle contraction directly, thereby reducing gallbladder size, inducing bile evacuation, and secretion of pancreatic enzymes. I tillegg, this agent decreases esophageal sphincter tone and delays gastric emptying via cholinergic signaling.

Sincalide is a cholecystokinetic administered by injection to aid in diagnosing disorders of the gallbladder and pancreas. It is the 8-amino acid C-terminal fragment of cholecystokinin, also known as CCK-8. Endogenous cholecystokinin is a gastrointestinal peptide hormone responsible for stimulating the digestion of fat and protein. When injected intravenously, sincalide produces a substantial reduction in gallbladder size by causing this organ to contract. The evacuation of bile that results is similar to that which occurs physiologically in response to endogenous cholecystokinin. Furthermore, sincalide stimulates pancreatic secretion of bicarbonate and enzymes.